alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF PENN-AKRON CORPORATION FOR THE QUARTER ENDED MAY 31,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   5-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAY-31-2000
<CASH>                                           2,922
<SECURITIES>                                         0
<RECEIVABLES>                                9,205,594
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             9,468,896
<PP&E>                                          39,808
<DEPRECIATION>                                  (4,565)
<TOTAL-ASSETS>                              10,034,438
<CURRENT-LIABILITIES>                        9,522,348
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        28,425
<OTHER-SE>                                     161,001
<TOTAL-LIABILITY-AND-EQUITY>                10,034,438
<SALES>                                              0
<TOTAL-REVENUES>                             6,294,683
<CGS>                                                0
<TOTAL-COSTS>                                6,055,420
<OTHER-EXPENSES>                               600,161
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (360,898)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (360,898)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (360,898)
<EPS-BASIC>                                      (0.02)
<EPS-DILUTED>                                    (0.02)


</TABLE>
Albert BROOKS, a/k/a Albert Tremayne Brooks, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-2871

District Court of Appeal of Florida, Second District.

Opinion filed October 18, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
A.P., Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-0171

District Court of Appeal of Florida, Second District.

Opinion filed October 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
[Federal Register Volume 74, Number 10 (Thursday, January 15, 2009)]
[Notices]
[Pages 2618-2619]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-731]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated October 9, 2008, and published in the Federal 
Register on October 17, 2008, (73 FR 61908), Fisher Clinical Services, 
Inc., 7554 Schantz Road, Allentown, Pennsylvania 18106, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as an importer of Noroxymorphone (9668), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
analytical research and clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Fisher Clinical Services, Inc. to import the basic 
class of controlled substance is consistent with the public interest, 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Fisher

[[Page 2619]]

Clinical Services, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR Sec.  
1301.34, the above named company is granted registration as an importer 
of the basic class of controlled substance listed.

    Dated: January 9, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E9-731 Filed 1-14-09; 8:45 am]
BILLING CODE 4410-09-P
Margaret Celeste LUCAS, Appellant, v. STATE of Florida, Appellee.

Nos. 1D17-1396 1D17-1398 (Consolidated for disposition)

District Court of Appeal of Florida, First District.

April 5, 2018

Andy Thomas, Public Defender, and Justin F. Karpf, Assistant Public Defender, Tallahassee, for Appellant.

Pamela Jo Bondi, Attorney General, and Steven E. Woods, Assistant Attorney General, Tallahassee, for Appellee.

Per Curiam.

We affirm Appellant's judgment and sentence but remand for the trial court to enter a *nunc pro tunc* order consistent with its oral order adjudicating Appellant competent to proceed. *See**Merriell v. State* , 169 So.3d 1287, 1289 (Fla. 1st DCA 2015).

JAY, WINSOR, and M.K. THOMAS, JJ., concur.
<PAGE>
                                                                      Exhibit 99


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Medical Discoveries, Inc. (the
"Company") on Form 10-QSB for the quarterly period ended June 30, 2002 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Judy M. Robinett, President and Chief Executive Officer of the Company and
principal financial officer, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.



 /s/  JUDY M. ROBINETT
----------------------------------------
Judy M. Robinett
President and Chief Executive Officer
August 14, 2002
Jeremy TURNER, Appellant, v. STATE of Florida, Appellee.

No. 1D17-1839

District Court of Appeal of Florida, First District.

January 10, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
[Federal Register Volume 83, Number 9 (Friday, January 12, 2018)]
[Notices]
[Page 1608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00437]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-28-2017]


Foreign-Trade Zone 186--Waterville, Maine; Application for 
Production Authority; Flemish Master Weavers; Subzone 186A; Invitation 
for Public Comment on Additional Information

    The FTZ Board is inviting public comment on a new submission by the 
City of Waterville, Maine, grantee of FTZ 186, containing additional 
information pertaining to the production application of Flemish Master 
Weavers (FMW). The application, which was subject to a public comment 
period through August 7, 2017, requests unrestricted authority for FMW 
to produce machine-made woven area rugs from foreign-status continuous 
filament polypropylene yarn within Subzone 186A at the FMW facility in 
Sanford, Maine. The new submission on which the FTZ Board is now 
inviting public comment includes additional information concerning the 
supply of domestically-produced continuous filament polypropylene yarn 
and additional HTSUS Subheadings to describe that yarn.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is February 12, 
2018. Rebuttal comments in response to material submitted during the 
foregoing period may be submitted during the subsequent 15-day period 
to February 26, 2018.
    A copy of the submission will be available for public inspection at 
the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 
21013, U.S. Department of Commerce, 1401 Constitution Avenue NW, 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's website, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
<a href="/cdn-cgi/l/email-protection#3c78555d5259127a55524a594e7c484e5d5859125b534a"><span class="__cf_email__" data-cfemail="8fcbe6eee1eaa1c9e6e1f9eafdcffbfdeeebeaa1e8e0f9">[email protected]</span></a> or (202) 482-1367.

    Dated: January 8, 2018.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2018-00437 Filed 1-11-18; 8:45 am]
 BILLING CODE 3510-DS-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Odalys AREVALO, et al., Appellant(s)/Petitioner(s), v. QUANTUM HEALTH GROUP, LLC, et al., Appellee(s)/Respondent(s),

CASE NO.: 3D16-2356

District Court of Appeal of Florida, Third District.

MARCH 07, 2017

**DECISION WITHOUT PUBLISHED OPINION**

ORDERED.
<PAGE>

                                                                    EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  PURSUANT TO RULE 13A-14(B) OR 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF
    1934 AND SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE

      In connection with the Quarterly Report of NGAS Resources, Inc., a British
Columbia corporation (the "Company"), on Form 10-QSB (the "Report") for the
quarter ended September 30, 2004 (the "Reporting Period"), as filed with the
Securities Exchange Commission on the date hereof under the Securities Exchange
Act of 1934, as amended (the "Exchange Act"), the undersigned, William S.
Daugherty, Chairman, Chief Executive Officer and President of the Company,
certifies pursuant to Rule 13a-14(b) under the Exchange Act and Section 1350 of
Chapter 63 of Title 18 of the United States Code, that:

      1. The Report fully complies with the requirements of Section 13(a) of the
Exchange Act; and

      2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company as of the dates and for the periods reported therein.

/s/ William S. Daugherty

William S. Daugherty
Chairman, Chief Executive Officer and President
November 9, 2004
Exhibit 10.4


 


February 10, 2022

 HNRAC Sponsors, LLC

 3730 Kirby Drive


Suite 1200


Houston, Texas 77098


 


Gentlemen:


 


This letter
will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the registration
statement on Form S-1 (the “Registration Statement”) for the initial public offering (the “IPO”)
of the securities of HNR Acquisition Corp (the “Company”) and continuing until the earlier of (i) the consummation
by the Company of an initial business combination (a “Business Combination”) or (ii) the Company’s liquidation
(in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”),
HNRAC Sponsors LLC (“Sponsor”) shall make available to the Company certain office space, utilities, secretarial
and administrative services as may be required by the Company from time to time, situated at 3730 Kirby Drive, Suite 1200 Houston, Texas
77098 (or any successor location). In exchange therefore, the Company shall pay Sponsor a sum equal to $10,000 per month, commencing on
the Effective Date and continuing monthly thereafter until the Termination Date. Sponsor agrees that payment of such amounts may be deferred,
without interest, until the date of consummation by the Company of the initial Business Combination upon a determination by the Company’s
audit committee that the Company lacks sufficient funds held outside the Trust Account (as defined below) to pay the Company’s actual
or anticipated expenses in connection with the Company’s initial Business Combination. Sponsor hereby agrees that it does not have
any right, title, interest or claim of any kind in or to any monies that may be set aside in a trust account (the “Trust Account”)
that may be established by the Company for the benefit of the Company’s public stockholders upon the consummation of the IPO as
described in the Registration Statement (“Claim”) and hereby waives any Claim it may have in the future as
a result of, or arising out of, any negotiations, contracts or agreements with the Company in connection with this letter agreement and
will not seek recourse against the Trust Account for any reason whatsoever.


 


Very truly yours


 


	HNR ACQUISITION CORP. 	 
	 	 	 
	By:	/s/ Donald H. Goree	 
	Name: 	Donald H. Goree	 
	Title:	Chairman and Chief Executive Officer	 



 


Signature Page Administrative Services Agreement

 



    


     


    

 


	AGREED TO AND ACCEPTED BY:	 
	 	 
	HNRAC SPONSORS LLC	 
	 	 
	By:	
    /s/ Donald W. Orr
	 
	Name: 	Donald W. Orr	 
	Title:	Manager	 



 


Signature Page Administrative Services Agreement
**Exhibit 32.2**

 

**CERTIFICATION OFPRINCIPAL ACCOUNTING OFFICEROF TRM CORPORATIONAS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002, 18 U.S.C.SECTION 1350**

 

 

Pursuant to 18U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-OxleyAct of 2002, I, Rebecca J. Demy, Principal Accounting Officer of TRMCorporation (the “Company”), hereby certify that the accompanying QuarterlyReport of the Company on Form 10-Q for the quarterly period ended June 30,2003 (the “Report”), fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 and that the information containedin the Report fairly presents, in all material respects, the financialcondition and results of operations of the Company.

 

 
| Dated:  August 14, 2003 | /s/ Rebecca  J. Demy          |   |
|------------------------------|-------------------------------|--------|
|                         | Rebecca J.  Demy              |
|                         | Principal  Accounting Officer |

 

----
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5590 Introduced in House (IH)]

109th CONGRESS
  2d Session
                                H. R. 5590

   To amend the Internal Revenue Code of 1986 to provide individuals 
                relief from the alternative minimum tax.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 13, 2006

 Mr. Reynolds (for himself, Mr. English of Pennsylvania, Mr. Hayworth, 
Mr. Weller, Mr. Lewis of Kentucky, Mr. Foley, Mr. Linder, Mr. Sweeney, 
   Mr. McCotter, Mr. Wilson of South Carolina, Mrs. Jo Ann Davis of 
    Virginia, Mr. Schwarz of Michigan, Ms. Harris, Mr. Tiberi, Mr. 
   Ferguson, Mr. McHugh, Mrs. Drake, Mr. Garrett of New Jersey, Mr. 
 Gillmor, Ms. Ginny Brown-Waite of Florida, Mr. Conaway, Mr. Kingston, 
Mrs. Myrick, Mrs. Bono, Mr. Sessions, Mr. Westmoreland, Ms. Jackson-Lee 
 of Texas, Mr. Kuhl of New York, Mr. Simmons, Mr. Smith of Texas, Mr. 
 Wicker, Mrs. Kelly, Mr. Kline, Mr. Kennedy of Minnesota, Mr. Murphy, 
and Mrs. Biggert) introduced the following bill; which was referred to 
                    the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
   To amend the Internal Revenue Code of 1986 to provide individuals 
                relief from the alternative minimum tax.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stealth Tax Relief Extension Act of 
2006''.

SEC. 2. INCREASE IN ALTERNATIVE MINIMUM TAX EXEMPTION AMOUNT FOR 2007.

    (a) In General.--Section 55(d)(1) of the Internal Revenue Code of 
1986 (relating to exemption amount for taxpayers other than 
corporations) is amended--
            (1) by striking ``$62,550 in the case of taxable years 
        beginning in 2006'' in subparagraph (A) and inserting ``$66,100 
        in the case of taxable years beginning in 2007'', and
            (2) by striking ``$42,500 in the case of taxable years 
        beginning in 2006'' in subparagraph (B) and inserting ``$44,900 
        in the case of taxable years beginning in 2007''.
    (b) Effective Date.--The amendments made by this section shall 
apply to taxable years beginning after December 31, 2006.

SEC. 3. ALLOWANCE OF NONREFUNDABLE PERSONAL CREDITS AGAINST REGULAR AND 
              ALTERNATIVE MINIMUM TAX LIABILITY.

    (a) In General.--Paragraph (2) of section 26(a) of the Internal 
Revenue Code of 1986 is amended--
            (1) by striking ``2006'' in the heading thereof and 
        inserting ``2007'', and
            (2) by striking ``or 2006'' and inserting ``2006, or 
        2007''.
    (b) Effective Date.--The amendments made by this section shall 
apply to taxable years beginning after December 31, 2006.
                                 <all>
```
<PAGE>

                                                                    Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Medical Discoveries, Inc. (the
"Company") on Form 10-QSB for the quarter ended September 30, 2005 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Dierdra J. Burgess, Controller, certify pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge and belief:

      (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: November 14, 2005                   /s/ Dierdra J. Burgess
                                           ----------------------
                                           Dierdra J. Burgess
                                           Controller

      A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff
upon request. The foregoing certifications are accompanying the Company's Form
10-QSB solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of Section 1350, chapter 63 of title 18, United States
Code) and is not being filed as part of the Form 10-QSB or as a separate
disclosure document.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commission on Civil Rights

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission), and the Federal Advisory Committee Act (FACA), that a meeting of the Arkansas Advisory Committee to the Commission will convene on Wednesday, February 11, 2009 at 1:30 p.m. and adjourn at approximately 3:30 p.m. at the University of Arkansas at Little Rock, William H. Bowen School of Law. The purpose of the meeting is to conduct long range planning for future activities in 2009-10.

                    Members of the public are entitled to submit written comments. The comments must be received in the regional office by February 4, 2009. The address is U.S. Commission on Civil Rights, 400 State Avenue, Suite 908, Kansas City, Kansas 66101. Persons wishing to e-mail their comments, or to present their comments verbally at the meeting, or who desire additional information should contact Farella E. Robinson, Regional Director, Central Regional Office, at (913) 551-1400 or by e-mail to                     *frobinson@usccr.gov.*

Hearing-impaired persons who will attend the meeting and require the services of a sign language interpreter should contact the Regional Office at least ten (10) working days before the scheduled date of the meeting.

                    Records generated by this meeting may be inspected and reproduced at the Central Regional Office, as they become available, both before and after the meeting. Persons interested in the work of this advisory committee are advised to go to the Commission's Web site,                     *http://www.usccr.gov,*                     or to contact the Central Regional Office at the above e-mail or street address.                

The meeting will be conducted pursuant to the provisions of the rules and regulations of the Commission and FACA.

Dated in Washington, DC, January 12, 2009.

Christopher Byrnes,

Chief, Regional Programs Coordination Unit.

 [FR Doc. E9-766 Filed 1-15-09; 8:45 am]

BILLING CODE 6335-01-P
STATE EX REL. Clifford BRAUD v. STATE of Louisiana

No. 2015-KH-0701

Supreme Court of Louisiana.

March 2, 2018

**ON SUPERVISORY WRITS TO THE CRIMINAL DISTRICT COURT, PARISH OF ORLEANS**

PER CURIAM:

Writ granted. In light of the Supreme Court's holding in *Montgomery v. Louisiana* , 577 U.S. ----, 136 S.Ct. 718, 193 L.Ed.2d 599 (2016) that *Miller v. Alabama* , 567 U.S. 460, 132 S.Ct. 2455, 183 L.Ed.2d 407 (2012) announced a substantive rule of constitutional law that applies retroactively, we vacate relator's sentence and remand this case to the Orleans Parish Criminal District Court for further *505proceedings consistent with the views expressed in *State v. Montgomery* , 13-1163 (La. 6/28/16), 194 So.3d 606, and for resentencing pursuant to La.C.Cr.P. Art. 878.1. We further note that, after defendant is resentenced, that judgment is included by statute among those which defendant may appeal. *See* La.C.Cr.P. art. 912(C)(1).
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

KEVIN HAMILTON,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 371 WAL 2019

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 6th day of April, 2020, the Petition for Allowance of Appeal is 

DENIED.
Bradley Alan DUGAN, Appellant, v. STATE of Florida, Appellee.

Case No. 2D15-4149

District Court of Appeal of Florida, Second District.

Opinion filed October 13, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.